OmniActive officially launched Nutritears, a multi-ingredient formula which targets dry eyes, in the U.S. The proprietary ingredient blend is the first product to be created using OmniActive’s Integrative Actives platform, which facilitates the delivery of multiple ingredients into concentrated, smaller doses. It features a combination of lutein, zeaxanthin isomers, curcuminoids, and vitamin D3.
 
“We have spent the last few months ramping up production to meet demand for our commercial launch and since its introduction in July, Nutritears has been well-received by those looking to address the multifaceted issues surrounding dry eye,” Isabel Lucas, director of Product Launch and Marketing Excellence. “We welcome SupplySide West attendees to visit us at our booth to discuss this novel, in demand, and clinically-demonstrated solution.”
 
According to a recent study on Nutritears, which was a randomized, placebo-controlled human trial involving 59 subjects, daily supplementation with the ingredient for two weeks resulted in “significant improvements in the production, stability, and quality of tears by reducing ocular surface damage and tear inflammation, and can be used as an adjuvant to artificial tears in subjects with dry eye syndrome,” as the authors concluded. A reduction in the need for artificial tears is considered a primary concern of inconvenience for dry eye syndrome, OmniActive reports, making it a substantial clinical endpoint.
 
“Our market research showed that there is an unmet need in the market for this type of product,” Akhil Bajaj, category manager, Vision and Cognitive Health at OmniActive, said. “More specifically, our consumer insights revealed that nearly three quarters of consumers consider dietary supplement solutions for occasional dry eye to be more or just as effective as current therapies such as eye drops.”